Search Within

Oliver Surriga

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Sloan Kettering Institute Postdocs (4)
  2. Biostatistics Service (1)
  3. Department of Medicine (1)
  4. Epidemiology and Biostatistics (1)
  5. Sarcoma Service (1)
  6. Solid Tumor Oncology Division (1)

More Groups

People
  1. Gary Schwartz (5)
  2. Grazia Ambrosini (5)
  3. Jeffrey Rothman (2)
  4. Rajasekhar Vinagolu (2)
  5. Christine Pratilas (1)
  6. Elisa De Stanchina (1)

More People

Years
  1. 2016 (1)
  2. 2014 (2)
  3. 2013 (2)
  4. 2012 (1)
Publications
  1. Cancer Research (2)
  2. Clinical Cancer Research (2)
  3. Annals of Oncology (1)
  4. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (5)
  2. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma
    Meeting Abstract

    Rothman, J. H.; Surriga, O.; Ambrosini, G.; Vasudeva, S.; Schwartz, G. K.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • PNA as novel targeted cancer therapy for BRAF(V600E) mutant melanoma
    Meeting Abstract

    Rothman, J. H.; Surriga, O.; Vasudeva, S. D.; Ambrosini, G.; Ouerfelli, O.; Schwartz, G. K.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs
    Journal Article

    Patwardhan, P. P.; Surriga, O.; Beckman, M. J.; de Stanchina, E.; DeMatteo, R. P.; Tap, W. D.; Schwartz, G. K.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Crizotinib, a selective c-Met inhibitor, prevents metastasis to the liver and lungs in a primary uveal melanoma mouse model
    Meeting Abstract

    Surriga, O.; Vinagolu, R.; Ambrosini, G.; Schwartz, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model
    Journal Article

    Surriga, O.; Rajasekhar, V. K.; Ambrosini, G.; Dogan, Y.; Huang, R.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2013)

    Fulltext@MSK | Save
  • Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance
    Journal Article

    Ambrosini, G.; Pratilas, C. A.; Qin, L. X.; Tadi, M.; Surriga, O.; Carvajal, R. D.; Schwartz, G. K.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save